Notices. DEPARTMENT OF HEALTH AND HUMAN SERVICES

278 words·~1 min read·/register/2002/02/13/02-3443

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended.

The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel. *Date:* February 28, 2002. *Time:* 3 p.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* 2 Democracy Plaza, 6707 Democracy Blvd., Room 746, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Maria E.

Davila-Bloom, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, Room 746, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892, 301-594-7637, *davila-bloomm@extra.niddk.nih.gov.* In the interest of security, NIH has instituted stringent procedures for entrance into the building by non-government employees. Persons without a government I.D. will need to show a photo I.D. and sign-in at the security building. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated:

February 6, 2002. LaVerne Y. Stringfield, Director, Office of Federal Advisory Committee Policy. [FR Doc. 02-3443 Filed 2-12-02; 8:45 am]